Wikipedia:Version 1.0 Editorial Team/MCB articles by quality log
 | This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record. |
January 19, 2025
[edit]Reassessed
[edit]- Gain-of-function research (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
- Thyroxine (talk) reassessed. Quality rating changed from Redirect-Class to B-Class. (rev · t)
Assessed
[edit]- Cell autonomous sex identity (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
January 18, 2025
[edit]Renamed
[edit]- IRGD renamed to IRGD peptides.
Reassessed
[edit]- Structural alignment (talk) reassessed. Quality rating changed from GA-Class to C-Class. (rev · t)
Assessed
[edit]- IRGD peptides (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
January 17, 2025
[edit]Reassessed
[edit]- Thrombopoietin receptor (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
January 16, 2025
[edit]Reassessed
[edit]January 13, 2025
[edit]Renamed
[edit]- ATP5G1 renamed to ATP5MC1.
- Permissiveness (biology) renamed to Permissiveness.
Assessed
[edit]- ATP5MC1 (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Permissiveness (endocrinology) (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Proton-pump inhibitors (talk) assessed. Quality assessed as Redirect-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Proton Pump Inhibitors (talk) assessed. Quality assessed as Redirect-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Retina amacrine cell (talk) assessed. Quality assessed as Redirect-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- The genetic aspects of acute myeloid leukemia (talk) assessed. Quality assessed as Redirect-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Therapy-related acute myeloid leukemia (talk) assessed. Quality assessed as Redirect-Class. (rev · t) Importance assessed as NA-Class. (rev · t)